Clinical Trial Update: Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports safety and quality-of-life outcomes for administering enfuvirtide (Fuzeon) using a Biojector versus conventional needles in HI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus

Drugs mentioned

• Fuzeon (enfuvirtide)

Snippet

Sponsor: Canadian Immunodeficiency Research Collaborative | Conditions: Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED